Dr. Erin Marsh Mellano, MD

Dr. Mellano practices at Seaside Surgical Center Inc in Torrance, California.

Dr. Mellano's NPI, 1720240328, was assigned on June 26, 2008. Dr. Mellano graduated from Keck School of Medicine of USC in 2008. Dr. Mellano holds California license A110493.

Dr. Mellano's primary practice is Seaside Surgical Center Inc, at 4201 Torrance Blvd, Torrance, CA 90503 in Los Angeles County. The practice phone is (310) 540-0144.

Dr. Mellano's primary practice is Seaside Surgical Center Inc in Torrance, California. Dr. Mellano is also affiliated with Torrance Memorial Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Mellano to 2 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mellano practices, 6 sites in all. Vendor and product names are available with a free account.

Gynecology is Dr. Mellano's primary specialty in the NPI Registry, under taxonomy code 207VG0400X. Dr. Mellano is board certified in female pelvic medicine and reconstructive surgery by the American Board of Obstetrics and Gynecology. Dr. Mellano is licensed in California.

Dmand AI lists bladder disease, hysterectomy, menopause, pelvic prolapse, UTI, vaginal infection, vaginal prolapse repair and vaginal repair among the conditions Dr. Mellano treats.

CMS data shows 6,210 Medicare services from Dr. Mellano across 21 procedure codes in 2024, for 659 Medicare patients. Medicare paid $182,349 for them. Every service was in an office.

CMS counts 659 Medicare patients who saw Dr. Mellano in 2024. The largest group is 65 to 74, with 285 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mellano's median patient age at 60, with 98% women.

In 2024, Dr. Mellano wrote 2,140 Medicare Part D claims for 558 patients. 80% of them were for generic drugs. CMS names the drug for 1,976 of them, across 37 drugs with 11 or more claims each, at $411,490 in total drug cost. In 2023, CMS named 1,672 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Mellano for performance year 2024, reported as part of a group. Dr. Mellano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mellano as offering telehealth. CMS counts 23 procedures of removal of skin lesions by Dr. Mellano, more than 66% of the clinicians it reports for that procedure.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Mellano. Dr. Mellano's most frequent co-authors are Karl Jallad, MD, Ja-Hong Kim, MD and Quinn Kerr Lippmann, MD, MPH.

CMS Open Payments shows 38 general payments to Dr. Mellano from 12 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 48% of the total. Medtronic, Inc. paid the most, $1,817.

Dr. Mellano graduated from Keck School of Medicine of USC in 2008.

Dr. Mellano is in network with 14 carriers, including United Healthcare, Elevance and HCSC. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.